Merck is Very Much a No Go - Data Research Scientist Merck Employee Review

1.0
Feb 28, 2016
Recommend
CEO approval
Business outlook

Pros

A few good people remain. Company benefits are average or above, other than tuition reimbursement which now is inadequate to earn a MS.

Cons

Very much a dying company. Astonishingly bad esprit de corps, much worse now than when I joined over a decade ago. In the past 3 years, 90% of R&D talent has left the company or transferred to other divisions. Upper management are trying to convert all the remaining R&D and IT tasks into mechanized processes to then outsource them (supposedly saving money). All corporate initiative focuses either on saving money or on promoting Keytruda.

Explore other reviews about Merck

5.0
Jun 3, 2026
Recommend
CEO approval
Business outlook

Pros

End of the year shutdown which includes paid time off

Cons

The con for me at the time was that I had to relocate which wasn’t possible

4.0
Jun 2, 2026
Recommend
CEO approval
Business outlook

Pros

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Cons

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

See reviews by: Helpful|Rating|Date|All